HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Stephen J. Rossiter Edward B. Stinson Philip E. Oyer Bruce A. Reitz Norman E. Shumway Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, D. C. Articles by Shumway, N. E. Search for Related Content PubMed PubMed Citation Articles by Miller, D. C. Articles by Shumway, N. E.

Ann Thorac Surg 1979;28:239-251
© 1979 The Society of Thoracic Surgeons

---

Articles

Late Right Heart Reconstruction Following Repair of Tetralogy of Fallot

From the Department of Cardiovascular Surgery, Stanford University School of Medicine, Stanford, CA.

^* Address reprint requests to Dr. Miller, Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA 94305.

Twenty-two symptomatic patients underwent a total of 28 reoperative procedures after initial surgical repair of tetralogy of Fallot. Sixteen of the patients were considered to have unfavorable anatomy of the right ventricular outflow tract (RVOT) or pulmonary artery at the time of initial repair. Pulmonary or tricuspid valve replacement, or replacement of both valves, utilizing a xenograft bioprosthesis was performed in 1 of the 22 initial repairs, 7 of the 22 first reoperations, and 5 of the 6 second reoperations. Ultimately, 14 patients received transannular RVOT patches. The interval between the first and second reoperations for 6 patients who required 2 late reconstructive procedures was 5.8 years.

No operative deaths occurred. There were 2 late deaths (1 sudden and 1 due to aspiration). Actuarial survival probability (± standard error of the mean) 16 years after initial repair was 72 ± 21%. Eighteen of the 20 current survivors in the present series are completely asymptomatic without physical restrictions; the other 2 are considered to be in New York Heart Association Functional Class II. No xenograft bioprosthetic dysfunction has occurred to date, but cumulative valve follow-up is limited (13 patient-years).

In selected patients, earlier pulmonary or tricuspid valve replacement or replacement of both of these valves can provide some degree of protection against recurrent deterioration.

This article has been cited by other articles:

				S. J. Finck, F. J. Puga, and G. K. Danielson Pulmonary Valve Insertion during Reoperation for Tetralogy of Fallot Ann. Thorac. Surg., June 1, 1988; 45(6): 610 - 613. [Abstract] [PDF]

				S. John, N. K. Kejriwal, E. Ravikumar, V. V. Bashi, B. B. Mohanty, and I. P. Sukumar The Clinical Profile and Surgical Treatment of Tetralogy of Fallot in the Adult: Results of Repair in 200 Patients Ann. Thorac. Surg., May 1, 1986; 41(5): 502 - 506. [Abstract] [PDF]

				H. E. Sanchez, E. M. Cornish, F. C. Shih, J. d. Nobrega, J. Hassoulas, J. Netto, R. E. Thornington, and C. N. Barnard The Surgical Treatment of Tetralogy of Fallot Ann. Thorac. Surg., May 1, 1984; 37(5): 431 - 436. [Abstract] [PDF]

				R. M. Shaher, E. Foster, M. Farina, E. Spooner, F. Sheikh, and R. Alley Right Heart Reconstruction Following Repair of Tetralogy of Fallot Ann. Thorac. Surg., April 1, 1983; 35(4): 421 - 426. [Abstract] [PDF]